GLP-1, The Quiet Revolution at the Restaurant Table, and Why Hop Water Arrives at Exactly the Right Moment
The drug changing what people eat, drink, and order and what the hospitality industry hasn't caught up with yet.
GLP-1 receptor agonists including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) significantly reduce alcohol and sugar cravings as a documented secondary effect. For the hospitality industry this creates a specific and growing challenge: a meaningful proportion of diners can no longer be served in the same way.
I was prompted to ask whether GLP-1 is impacting the gastronomic and hospitality industries following a conversation with a GLP-1 user. This individual works in customer relations within wealth management a role deeply intertwined with high-end hospitality and fine dining
Something is changing in dining rooms across Europe and North America. It is quiet, incremental, and almost invisible unless you know what to look for. Tables are leaving food on plates. Diners are ordering one glass of wine instead of a bottle. Dessert menus are being declined not apologetically but indifferently.
The explanation is not a cultural shift or a wellness trend. It is a pharmacological one.
GLP-1 receptor agonists semaglutide and tirzepatide, sold as Ozempic, Wegovy, Mounjaro, and Zepbound, have become the fastest-growing class of drugs in pharmaceutical history. Originally developed for type 2 diabetes management, they are now prescribed globally for weight management and metabolic health. By 2030, industry analysts project that 30 million people in the United States alone will be taking some form of GLP-1 medication. In the UK, NHS prescriptions for semaglutide have increased tenfold in two years. In Portugal and across southern Europe, private prescriptions are outpacing public health system adoption.
These drugs work, broadly, by mimicking the glucagon-like peptide-1 hormone the body produces after eating. They slow gastric emptying, reduce appetite signals, crucially for the hospitality industry dramatically alter cravings. Specifically, alcohol cravings and sugar cravings.
The restaurant industry has not yet fully understood what this means. It should.
What GLP-1 drugs actually do to appetite and cravings
The mechanism of GLP-1 agonists extends well beyond simple appetite suppression. The drugs act on reward pathways in the brain, the same dopaminergic circuits that make alcohol and sugar pleasurable. Multiple clinical studies have now documented a striking secondary effect: patients taking GLP-1 medications report a significant and often spontaneous reduction in alcohol consumption, sometimes approaching complete cessation, without being asked or instructed to reduce their drinking.
I spoke to a friend who is using GLP-1. His description of GLP-1 showed just how effective it truly is. He explained that it wasn't a matter of 'managing' cravings; he simply felt full. No matter how tempting the sommelier’s wine description or how beautifully presented the desserts were, he wasn't fighting a 'seduction.' The fundamental need to eat or drink simply wasn't there. No "Battle of the mind", just a quiet observational indifference.
A 2023 study published in the Journal of Clinical Psychiatry found that patients on semaglutide reported 50% reduction in alcohol cravings compared to a placebo group. Research from the University of Gothenburg found that GLP-1 receptor activation in the reward centres of the brain directly reduces the pleasurable anticipation of alcohol. Alcohol use disorder researchers are now conducting trials of GLP-1 drugs as a treatment for alcohol dependency not because anyone planned it that way, but because patients kept reporting that they simply stopped wanting to drink.
The sugar effect is equally documented. GLP-1 users consistently report that ultra-sweet foods desserts, sweetened drinks, high-sugar cocktails become actively unappealing. Not difficult to resist but genuinely undesirable. The neural reward signal that made a sugary cocktail feel like a treat is pharmacologically dampened. The drink arrives at the table and the person finds they no longer want it.
For the restaurant industry, this creates a specific and growing challenge. A meaningful and increasing proportion of diners are arriving at the table with fundamentally altered appetites, dramatically reduced alcohol consumption, and an active aversion to sugar and sweetness. They still want to eat. They still want to drink. They still want the experience of a sophisticated meal in a well-considered restaurant. But the drinks list has not caught up with their new physiological reality.
The hospitality industry's GLP-1 problem
The economics of a Michelin-starred or premium gastronomic restaurant depend significantly on beverage revenue. Food margins are historically thin — the kitchen is often a cost centre that the bar and wine list subsidise. A table that orders two bottles of wine and dessert wine generates dramatically more revenue than a table that eats the same food and drinks sparkling water throughout.
GLP-1 patients are not choosing to drink less wine because they are health-conscious or sober-curious. Their neurology is simply not generating the reward signal that makes wine feel desirable in the same way it did before. The sommelier approaches with the wine list and the physiological response that would normally create engagement and desire is pharmacologically muted.
This is not a small demographic. A recent Morgan Stanley analysis estimated that GLP-1 drugs could reduce caloric consumption at foodservice establishments by two to three percent over the next five years a number that sounds small until you map it onto the margin structure of a premium restaurant. Several major hospitality groups in the United States have already begun discussing GLP-1 adaptation strategies in their F&B planning.
The European market is approximately three to five years behind the US in GLP-1 adoption. But the trajectory is identical. Premium restaurants in Lisbon, London, Porto, and the Algarve are not yet experiencing GLP-1-driven revenue shifts at scale. They will be.
The question for a Michelin-starred property, a premium coastal restaurant, or a hotel dining room is not whether this is coming. It is whether they are ready when it arrives.
What the GLP-1 diner actually wants
This is where the conversation becomes specific and actionable for a drinks buyer.
The GLP-1 diner has not lost interest in sophisticated flavour. They have lost interest in alcohol and sugar as delivery mechanisms for that flavour. The complexity of a well-made wine, the botanical character, the dry finish, the interplay of aromatic compounds is still appealing in principle. The alcohol and residual sugar that carry it are not.
They are looking for something that delivers the sophistication of a considered drink without the pharmacological signals their medication is dampening. They want complexity without sweetness. Botanical depth without alcohol. Something that respects the meal and the setting without requiring them to drink something that their body is no longer responding to with pleasure.
The standard restaurant response to this need is inadequate. Sparkling water is presented as the polite alternative. A non-alcoholic beer arrives in a branded glass and creates an awkward association with a category they didn't want in the first place. A mocktail is constructed from fruit juice and cordials both heavily sweetened, both triggering the sugar aversion that GLP-1 has created.
None of these serve the GLP-1 diner well. None of them are what a gastronomic restaurant should be putting in front of a guest who has spent £180 on a tasting menu.
Some of Portugal's most forward-thinking restaurants are already thinking this way. Encanto by José Avillez, Lisbon's only Michelin-starred vegetarian restaurant, has recognised that a guest who has chosen a menu built entirely around plants and botanical complexity deserves a drink that operates at the same level. Perfect Peaks Hop Water is already on the menu. It is not a compromise. It is a considered choice that completes the philosophy of the meal.
Why hop water is the specific answer
Perfect Peaks Hop Water lands in this conversation with a precision that most drinks brands cannot claim.
Zero sugar. Completely. Not reduced sugar, not naturally sweetened, not fruit-juice sweetened. Zero. The GLP-1 patient whose aversion to sweetness makes most soft drinks and mocktails actively unpleasant will find nothing to object to in Perfect Peaks.
Zero alcohol. The pharmacological reduction in alcohol craving that GLP-1 creates is not a problem Perfect Peaks needs to overcome. It is the context in which Perfect Peaks makes perfect sense.
Botanical complexity from the hop terpene profile. The Citrus flavour, pink grapefruit peel, lime blossom, passionfruit, finishing dry and clean, has the aromatic sophistication of a well-made aperitif without any of the compounds the GLP-1 diner's neurology is no longer rewarding. The Tropical flavour offers mango, papaya, and fresh pine with the same dry botanical complexity. Both deliver what the sommelier conversation is supposed to deliver a considered, interesting, grown-up drink that respects the food and the setting.
The mouthfeel from the electrolyte minerals. Magnesium, calcium, and sodium salts give Perfect Peaks a crispness and body that plain sparkling water lacks. For a diner whose gastric emptying has been slowed by GLP-1 medication, meaning they are more sensitive to volume and weight in the stomach, a 250ml slim can of something genuinely interesting is more appropriate than a heavy glass of sparkling water or a large cocktail.
The parasympathetic support from the hop terpenes. GLP-1 medications have reported side effects including nausea, digestive discomfort, and mild anxiety, particularly in the early months of treatment. The myrcene and linalool in Perfect Peaks support GABA-A receptor sensitivity and parasympathetic nervous system dominance gently, botanically, without medication interaction concerns. A GLP-1 patient reaching for Perfect Peaks after dinner is reaching for something that works with their nervous system rather than against it.
The opportunity for the gastronomic restaurant
For a premium or Michelin-starred property, the GLP-1 conversation is not a problem to be managed. It is an opportunity to demonstrate the kind of intelligence and care that separates a great restaurant from a merely good one.
The sommelier who can present a Perfect Peaks Hop Water with the same fluency and enthusiasm they bring to a natural wine recommendation is telling the GLP-1 diner something important. You are seen here. Your experience of this meal has been thought about. You are not being handed sparkling water with a polite apology for the absence of anything better.
The menu descriptor matters enormously in this context. "Hop water sparkling water with natural flavouring" tells the GLP-1 diner nothing. "Perfect Peaks Hop Water, botanical sparkling water infused with pure Citra hop oil. Dry, floral, complex. Zero sugar, zero alcohol. Made in Cascais with hop oils from Kent." tells them everything they need to know and positions the drink as a considered choice rather than a consolation.
For a hotel property with a spa and wellness programme, the GLP-1 connection runs deeper. Many guests on weight management programmes using GLP-1 medications are specifically choosing wellness retreats to support their health journey. A property that understands GLP-1 pharmacology well enough to stock a drink specifically suited to those guests' altered physiology is operating at a level of guest intelligence that Relais and Châteaux, Leading Hotels, and Five Star Alliance buyers will recognise and value.
The broader cultural shift GLP-1 is accelerating
GLP-1 is not creating the reduction in alcohol and sugar consumption in isolation. It is accelerating a shift that was already happening.
The sober-curious movement, the rise of the no and low alcohol category, the clean-label wellness consumer, the endurance athlete who trains to manage cortisol all of these trends have been building for a decade. GLP-1 is adding a pharmacological driver to a cultural one. The two are now moving in the same direction simultaneously.
The consumer who is reducing alcohol for health reasons and the GLP-1 patient whose craving for alcohol has been pharmacologically reduced are arriving at the same place from different directions. Both are sitting at a restaurant table with a drinks list that was designed for a different era. Both are looking for something their host hasn't quite provided yet.
Perfect Peaks is that thing.
For the restaurant, the hotel, and the bar
The practical implication is straightforward.
A GLP-1-aware drinks list includes at least one option that is genuinely zero sugar, genuinely zero alcohol, and genuinely sophisticated, not a non-alcoholic beer, not a sweetened mocktail, not a premium sparkling water with a garnish. Something with botanical complexity, considered provenance, and the kind of flavour story a sommelier can tell at the table with conviction.
Perfect Peaks Citrus alongside a seafood tasting menu. Perfect Peaks Tropical alongside a creative vegetable course. A recommended pairing on the menu rather than an afterthought on the water list.
The restaurants that get ahead of the GLP-1 curve will not just serve a growing demographic more thoughtfully. They will demonstrate a guest intelligence that distinguishes them from competitors who are still handing sparkling water to the third of the table who isn't drinking wine.
The drug is already in the room. The question is whether the drinks list has caught up.
Written by Sean Wootton, founder of Perfect Peaks Hop Water and hop water specialist with ten years of brewing expertise
At Perfect Peaks we were an official partner of Ironman Portugal Cascais 2025 and 2026. Bronze at the World Alcohol Free Awards 2025. Available for wholesale enquiries at sean@perfectpeaksbrews.com or via the wholesale page at perfectpeaksbrews.com.
Your endorphin glow. Uncontaminated.